How one father built a biotech, Grace Science, to save his daughter
Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
FDA approves Vera Therapeutics kidney disease treatment
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
UpDoc cleared by FDA as generative AI raises questions| STAT
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
Anthropic, AI powerhouse, announces it will begin developing drugs of its own
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Anthropic releases Claude Science, sees Claude Code level impact
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Medicare will soon cover obesity drugs, but many seniors may not know
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
2026 pharma and biotech deal-making already tops 2025 total
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
FDA pilot program aims to speed up early-stage clinical trials
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Netizens spiral over IIT Roorkee’s cow urine study, findings reveal potential to fight Chikungunya virus
IIT Roorkee researchers have identified key bioactive compounds in Ayurvedic Cow Urine Distillate (Gau Mutra Ark), demonstrating significant…
Eli Lilly ends 340B drug discounts to some hospitals over missing claims data
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…